The construction project of anti Xinguan drug production base of the group's Xiansheng pharmaceutical started

On the morning of June 8, the construction project of the commercial production base of anti Xinguan drugs of Xiansheng Pharmaceutical Co., Ltd., which was contracted by the group company, held a commencement ceremony in Jiangbei new area, Nanjing. Ma Jinshan, vice president of the group company and head of Nanjing company, attended the event. The base focuses on the planning and production of anti novel coronavirus drugs, which are used for the prevention and treatment of close contact people who have been exposed to the positive test of neocoronavirus, and help the rapid formation of a three-dimensional prevention and control system in China that takes vaccines as prevention and oral administration as treatment, which provides a solid guarantee for the success of anti epidemic. It is an anti epidemic project that the group company participates in again outside the construction of vaccine workshops. The project was approved and filed in early May. At present, the pile foundation construction permit has been obtained, and the "four supplies and one leveling" on site is being promoted at full speed. It is planned to complete the capping of ssd8432 production workshop by the end of October this year, and strive to put into production by the end of the year. (Nanjing company)